Literature DB >> 2486441

Why women live longer than men: the biologic mechanism of the sex differential in longevity.

W R Hazzard1, D Applebaum-Bowden.   

Abstract

1. Exogenous sex steroids appear to influence lipoproteins in a manner that is a caricature of the effects of endogenous sex steroids: Estrogens raise HDL (selectively HDL2) and lower LDL; Androgens lower HDL (selectively HDL2), while raising LDL. 2. Exogenous sex steroids are likely to affect LDL metabolism via effects on the LDL receptor; Estrogens increase LDL receptor activity (in non-human species at both the hepatic cellular and mRNA levels, though this is yet to be confirmed in humans); ??Androgens decrease LDL receptor activity (yet to be tested in either human or non-human species). 3. Exogenous sex steroids appear to alter HDL levels predominantly via modulation of HDL catabolism; Estrogens retard HDL catabolism (33) (and may also increase apo A-I synthesis and HDL production); Androgens accelerate HDL catabolism (30). 4. Modulation of HDL (and possibly LDL) metabolism by sex steroids may be mediated by alterations in hepatic triglyceride lipase (HTGL) activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2486441      PMCID: PMC2376508     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  30 in total

Review 1.  Biological basis of the sex differential in longevity.

Authors:  W R Hazzard
Journal:  J Am Geriatr Soc       Date:  1986-06       Impact factor: 5.562

2.  Menopausal oestrogen therapy and protection from death from ischaemic heart disease.

Authors:  R K Ross; A Paganini-Hill; T M Mack; M Arthur; B E Henderson
Journal:  Lancet       Date:  1981-04-18       Impact factor: 79.321

3.  Differential mortality by sex in fetal and neonatal deaths.

Authors:  M M McMillen
Journal:  Science       Date:  1979-04-06       Impact factor: 47.728

4.  High density lipoproteins during hypolipidemic therapy. A comparative study of four drugs.

Authors:  M C Cheung; J J Albers; P W Wahl; W R Hazzard
Journal:  Atherosclerosis       Date:  1980-03       Impact factor: 5.162

5.  Hydrolysis of human plasma high density lipoprotein 2- phospholipids and triglycerides by hepatic lipase.

Authors:  K Shirai; R L Barnhart; R L Jackson
Journal:  Biochem Biophys Res Commun       Date:  1981-05-29       Impact factor: 3.575

6.  Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.

Authors:  E Hirvonen; M Mälkönen; V Manninen
Journal:  N Engl J Med       Date:  1981-03-05       Impact factor: 91.245

7.  A prospective study of postmenopausal estrogen therapy and coronary heart disease.

Authors:  M J Stampfer; W C Willett; G A Colditz; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1985-10-24       Impact factor: 91.245

8.  Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.

Authors:  W R Hazzard; S M Haffner; R S Kushwaha; D Applebaum-Bowden; D M Foster
Journal:  Metabolism       Date:  1984-09       Impact factor: 8.694

9.  The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E.

Authors:  E E Windler; P T Kovanen; Y S Chao; M S Brown; R J Havel; J L Goldstein
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

10.  The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol.

Authors:  D Applebaum-Bowden; S M Haffner; W R Hazzard
Journal:  Metabolism       Date:  1987-10       Impact factor: 8.694

View more
  7 in total

1.  Early mortality surge in protein-deprived females causes reversal of sex differential of life expectancy in Mediterranean fruit flies.

Authors:  H G Müller; J L Wang; W B Capra; P Liedo; J R Carey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

2.  Sex-dependent difference in the relationship between adipose-tissue cholesterol efflux and estradiol concentrations in young healthy humans.

Authors:  Fatima Iqbal; William J Durham; Ayyash Melhem; Saleem Raslan; Tony T Tran; Traver J Wright; Rabia Asghar; Ken Fujise; Elena Volpi; Labros Sidossis; Nicola Abate; Melinda Sheffield-Moore; Demidmaa Tuvdendorj
Journal:  Int J Dev Neurosci       Date:  2017-07-12       Impact factor: 2.457

3.  In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters.

Authors:  Demidmaa Tuvdendorj; Alejandro O Munoz; Viviana Ruiz-Barros; Jean-Marc Schwarz; Giuseppe Montalto; Manisha Chandalia; Lawrence C Sowers; Manfredi Rizzo; Elizabeth J Murphy; Nicola Abate
Journal:  Atherosclerosis       Date:  2016-06-13       Impact factor: 5.162

4.  Relationships of sex hormone levels with leukocyte telomere length in Black, Hispanic, and Asian/Pacific Islander postmenopausal women.

Authors:  Yan Song; Michele Cho; Kathleen M Brennan; Brian H Chen; Yiqing Song; JoAnn E Manson; Andrea L Hevener; Nai-Chieh Y You; Anthony W Butch; Simin Liu
Journal:  J Diabetes       Date:  2017-08-25       Impact factor: 4.006

Review 5.  What demographers can learn from fruit fly actuarial models and biology.

Authors:  J R Carey
Journal:  Demography       Date:  1997-02

Review 6.  Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative.

Authors:  Barbara V Howard; Jacques E Rossouw
Journal:  Curr Opin Lipidol       Date:  2013-12       Impact factor: 4.776

Review 7.  Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.

Authors:  Fatima Iqbal; Wendy S Baker; Madiha I Khan; Shwetha Thukuntla; Kevin H McKinney; Nicola Abate; Demidmaa Tuvdendorj
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.